Sensex

Thursday, February 21, 2008

DG - Subprime Loss : $70bn & Counting....

Check the amount of losses due to the subprime crisis for big guns of the financial sector. And remember.... its just the beginning.

 

Bank

Loss

Citigroup:

$18.0 billion

UBS:

$13.5 billion

Morgan Stanley:

$9.4 billion

Merrill Lynch:

$8.0 billion

HSBC:

$3.4 billion

Bear Stearns:

$3.2 billion

Deutsche Bank:

$3.2 billion

Bank of America:

$3.0 billion

Barclays:

$2.6 billion

Royal Bank of Scotland:

$2.6 billion

IKB:

$2.6 billion

Freddie Mac:

$2.0 billion

Credit Suisse:

$1.0 billion

Wachovia:

$1.1 billion

 

The list, complied by BBC from company reports and reported on its website, totals over $70 billion declared losses to date.

The list does not include the $2bn loss reported by SocGen, and smaller losses such as BNP Paribas, Bank of Tokyo-Mitsubishi UFJ and others many of whom are reporting $500 milllion or more losses.

According to a report, it is estimated that ultimately losses suffered by financial institutions could be between $220 billion and $450 billion as the $1 trillion in subprime mortage bonds is revalued.

 

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

New business?

Get new customers.

List your web site

in Yahoo! Search.

Find helpful tips

for Moderators

on the Yahoo!

Groups team blog.

.

__,_._,___

DG - FW: Sharekhan Post-Market Report dated February 21, 2008

 

 

From: The Sharekhan Research Team [mailto:marketwatch@research.sharekhan.com]
Sent: 21 February 2008 19:37
To: The Sharekhan Research Team
Subject: Sharekhan Post-Market Report dated February 21, 2008

 

 

 Sharekhan's daily newsletter

Visit us at www.sharekhan.com

 

February 21, 2008

 

Index Performance

Index

Sensex

Nifty

Open

17,825.22

5,156.90

High

17,911.66

5,241.35

Low

17,482.31

5,120.05

Today's Cls

17,734.68

5,191.80

Prev Cls

17,617.60

5,154.45

Change

117.08

37.35

% Change

0.66

0.72

 

Market Indicators

Top Movers (Group A)

Company

Price 
(Rs)

%
chg

Gainers

Hexaware

79.55

10.56

Satyam Computer

458.20

8.45

Polaris Lab

99.35

7.58

ING Vysya Bank

323.10

7.32

Hindalco Industries

189.45

7.22

Losers

Indian Hotels

124.50

-6.14

Bank of Baroda

380.20

-5.19

Punjab National Bank

581.40

-5.09

Union Bank

186.45

-4.58

Canara Bank

275.10

-4.41

Market Statistics

-

BSE

NSE

Advances

1,459

710

Declines

1,251

470

Unchanged

73

25

Volume(Nos)

28.77cr

49.92cr

 Market Commentary 

IT stocks rally in volatile market

While most of the stocks slipped from higher levels, IT stocks held on to their gains and ended firm.

The Sensex showed a smart recovery towards the close after shedding over 430 points from the day's high of 17,912.The market remained volatile despite positive cues 

 

from Asian and US markets. Banking and capital goods stocks witnessed selling pressure throughout the trading session, however, select buying in IT and metal stocks saw the Sensex recover from its low of 17,482. The mood turned bullish towards the close as European indices showed tremendous strength in opening trades, and the market surged on short covering in index pivotal stocks. The Sensex finally ended firm with a gain of 117 points at 17,735. The broad-based Nifty too showed a recovery and closed firm at 5,192, up 37 points.

The market breadth was positive, with the gainers outpacing the losers in a ratio of 1.19:1 on the Bombay Stock Exchange (BSE). Of the 2,783 stocks traded on the BSE, 1,459 stocks advanced, 1,251 stocks declined and 73 stocks ended unchanged. Barring the BSE Bankex index and the BSE CG index, most of the sectoral indices recovered from their lows and ended firm. The BSE IT index surged by 5.33% followed by the BSE Metal index (up 4.12%) and the BSE Teck index (up 3.24%). While the BSE Bankex index slipped 1.05% and the BSE CG index fell 0.62%.

Select counters logged steady gains. Satyam Computer rallied sharply by 8.45% at Rs458, Hindalco surged 7.22 % at Rs189, Wipro advanced 4.95% at Rs432, Infosys added 3.96% at Rs1,630, TCS moved up 3.89% at Rs918, Ambuja Cement jumped by 3.28% at Rs120, Bajaj Auto gained 3.05% at Rs2,411 and HLL was up 2.76% at Rs220. However, HDFC slipped 3.75% at Rs2,649, while ICICI Bank, BHEL, SBI and Grasim were down over 1% each.

Over 2.25 crore RNRL shares changed hands on the BSE followed by Centurion Bank of Punjab (1.58 crore shares), Ispat Industries (1.11 crore shares), Essar Oil (84.37 lakh shares) and Gujarat NRE coke (82.92 lakh shares).

Valuewise, Reliance Capital clocked a turnover of Rs307 crore on the BSE followed by RNRL (Rs302 crore), Reliance Power (Rs241 crore), Essar Oil (Rs200 crore) and Reliance Energy (Rs158 crore).

European Indices at 16:15 IST on 21-02-2008

Index

Level

Change (pts)

Change (%)

FTSE 100

5965.40

71.80

1.22

CAC 40 Index

4875.83

63.02

1.31

Dax Index

6993.04

93.36

1.35

 

Asian Indices at close on 21-02-2008

Index

Level

Change (pts)

Change (%)

Nikkei

13688.28

377.91

2.84

Hang Seng

23623

32.42

0.14

Kospi Index

1704.36

16.45

0.97

Straits Times

3054.81

27.98

0.92

Jakarta Composite

2734.68

117.08

0.66

To know more about our products and services, click here.

“This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. 
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.”

To unsubscribe write to myaccount@sharekhan.com

 

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Search Ads

Get new customers.

List your web site

in Yahoo! Search.

10 Day Club

on Yahoo! Groups

Share the benefits

of a high fiber diet.

.

__,_._,___

DG - Tax Calculator 2007-08

Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

New business?

Get new customers.

List your web site

in Yahoo! Search.

Popular Y! Groups

Is your group one?

Check it out and

see.

.

__,_._,___

DG - Budget Expectations : Religare

Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Ads on Yahoo!

Learn more now.

Reach customers

searching for you.

Best of Y! Groups

Check out the best

of what Yahoo!

Groups has to offer.

.

__,_._,___

DG - India Strategy Goldman Sachs

Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Curves on Yahoo!

A group for women

to share & discuss

food & weight loss.

Cat Zone

on Yahoo! Groups

Join a Group

all about cats.

.

__,_._,___

DG - IPO Document by PWC : Bilcare

Dear All

Please find a information document on IPO by PWC

Regards

Rohit

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Best of Y! Groups

Discover groups

that are the best

of their class.

Yahoo! Groups

Wellness Spot

A resource for Curves

and weight loss.

.

__,_._,___

DG - Sharekhan Investor's Eye dated February 20, 2008

 

Investor's Eye
[February 20, 2008] Please see the attachment for details

Sharekhan
www.sharekhan.com

Summary of Contents

SHAREKHAN BUDGET SPECIAL

Run-up to Budget 2008-09

In all probability the last budget to be presented by the United Progressive Alliance government is likely to be a populist budget, considering the general parliamentary elections in 2009 and the forthcoming elections in some of the politically important states like Rajasthan, Madhya Pradesh, Delhi and Chattisgarh. In line with this, the finance minister is likely to substantially increase the allocation for health, rural development and employment generation schemes. Moreover, we expect some relaxation in tax structure that would benefit the lower- and middle-income population (the Aam admi).


STOCK UPDATE

Ranbaxy Laboratories
Cluster: Apple Green
Recommendation: Buy
Price target: Rs558
Current market price: Rs412

Board clears proposal for hiving off discovery R&D

Key points

  • The board of Ranbaxy Laboratories (Ranbaxy) has cleared a scheme of demerger of the company's New Drug Discovery Research (NDDR) unit into a subsidiary, Ranbaxy Life Science Research Ltd (RLSRL). The demerger scheme is subject to requisite approvals.
  • Under the scheme of demerger, all assets, liabilities, research personnel and pipeline related to the NDDR unit will be transferred to RLSRL. In consideration, each shareholder of Ranbaxy will receive one equity share of Re1 each of RLSRL for every four equity shares of Rs5 each held in Ranbaxy.
  • The demerged company will be an independent company, the equity shares of which will be listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE), while global depositary receipts (GDR) will be listed at the Luxembourg Stock Exchange. All approvals required for the scheme to come into effect are expected in the 2nd half of 2008.
  • The demerger will enable the company to explore various funding options for the NDDR projects as well as allow for enhanced focus and dedicated resources for long-term value creation.
  • The demerger will also improve the profitability of the core manufacturing business. The management has indicated that the demerger will result in savings of approximately $25 million in CY2008. The savings have already been factored into our estimates. 
  • At the current market price of Rs412, Ranbaxy is trading at 19.3x its base CY2008E earnings and 16.8x its base CY2009E earnings. We maintain our Buy recommendation on the stock with the sum-of-the-parts price target of Rs558 (20x CY2009E earnings of base business plus Rs68 for exclusivity opportunities).

 

SEAMEC
Cluster: Ugly Duckling
Recommendation: Buy
Price target: Rs273
Current market price: Rs165

Price target revised to Rs273

Result highlights

  • Q4CY2007 results of SEAMEC have been quite disappointing. The revenues during the quarter declined by 64% year on year (yoy) to Rs22.3 crore from Rs61.6 crore due to lesser deployment of vessels. During the quarter, SEAMEC III was the only vessel that was fully deployed, while SEAMEC II and SEAMEC IV were not operational due to up-gradation or repair work for longer duration than expected. SEAMEC I was also under-utilised due to premature termination of contract.
  • The company registered an operating loss of Rs11.6 crore as against the operating profit of Rs30.4 crore during the corresponding quarter last year (Q4CY2006). The company incurred dry docking expense of Rs10.3 crore during the quarter.
  • The company suffered a net loss of Rs15.9 crore during the quarter as against the net profit of Rs25.9 crore during Q4CY2006 on account of lower revenue generation and higher dry docking expenses.
  • On yearly basis, the revenues registered a modest growth of 7.1% to Rs170.4 crore, while the operating profit declined by 28.2% to Rs50.8 crore.
  • With SEAMEC II to be out of operations for a minimum of six-month duration and delay in up-gradation of SEAMEC IV, we expect the company's performance to suffer during H1CY2008. Consequently, we are downgrading our CY2008 estimates to Rs23.1 per share from the earlier estimate of Rs33.5 per share. 
  • At the current market price, the stock trades at 7.2x CY2008 and 5.2x CY2009 estimated earnings. We maintain our Buy recommendation on the stock with a revised price target of Rs273 (8.5x CY2009 earnings).

 

Crompton Greaves
Cluster: Apple Green
Recommendation: Buy
Price target: Rs423 
Current market price: Rs313

Price target revised to Rs423

Key points

  • The M9FY2008 performance of Crompton Greaves Ltd (CGL) has been below our expectations. The power system business of the company displayed sluggish growth in its revenues. While in Q2 the revenue growth saw a set back due to a fire in a transformer plant, the Q3 revenues grew by only 13.1% due to logistical problem and delay in the delivery of orders.
  • In the recent conference call, the management of the company has guided for a revenue growth of 19% in the power business, 20% in the industrial business and 15% in the consumer business in FY2008. The guidance was below our earlier estimates, leading us to the downgrade our estimates.
  • In this report, we are also introducing our FY2010 earning estimates and expect CGL revenues and profits to grow at a compounded annual growth rate (CAGR) of 21.6% and 33.7% respectively over FY2007-10E.
  • The standalone order book of the company remained flat at Rs2,175 crore, while the consolidated order book of the group stood at USD1.3 billion. We expect the order inflow to pickup from Q4FY2008 onwards.
  • On a consolidated basis, the company reported net sales of Rs1,713.5 crore, while the net profit was at Rs82.7crore. The consolidated operating profit margin (OPM) increased by 80 basis points quarter on quarter (qoq) to 10.9%. An year-on-year (y-o-y) comparison could not be made, as the quarterly consolidated numbers were not reported earlier.
  • We have downgraded our earnings estimates by 8.8% and 4% respectively for FY2008 and FY2009. Our revised earning per share (EPS) estimates now stands at Rs10.6 and Rs14.4 for FY2008 and FY2009 respectively.
  • We remain bullish on the stock and reiterate Buy recommendation with a revised price target of Rs423. We have valued CGL based on 23x FY2010E EPS, which is based at 15% premium to our target multiple of Thermax.
  • CGL is one of the largest players in the power sector and with the acquisition of Pauwel, Ganz, and Microsol has plugged the gaps in its products and services offerings. We believe these valuations are attractive because of (a) Robust operating performance of the company on a standalone basis; (b) Higher geographical width and product depth of the company due to its subsidiaries and (c) Management's expertise in turning around the operations of the subsidiaries. At the current market price, the stock trades at 21.7x and 17x its FY2009E and FY2010E consolidated earnings.         

Regards,
The Sharekhan Research Team

myaccount@sharekhan.com 

 

__._,_.___
Regards

BigGains !!
Recent Activity
Visit Your Group
Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

New business?

Get new customers.

List your web site

in Yahoo! Search.

How-To Zone

on Yahoo! Groups

Find garden, home

& auto groups.

.

__,_._,___